About GenelexIncorporated in Washington State in 1987, Genelex is a privately held corporation providing comprehensive DNA testing services that enhance the health and safety of society. Poised to enter a period of rapid and sustained growth, the company is seeking additional corporate partners, DNA testing distributors, accredited investors and imaginative, dedicated employees and advisors. A pioneer in the field of human DNA testing, Genelex has been helping physicians find the right drug and dose for their pateints since 2000. GeneMedRx. GeneMedRx is the first software tool available to prescribers that predicts potential drug-drug and drug-gene interaction risk based on both cytochrome P450 metabolism and genetic testing. This information helps physicians gain enhanced understanding of metabolism-based adverse drug interactions and/or lack of efficacy. Contract Services. Genelex has a worldwide network of contract clients that offer our lab services. Top Rated by Customers, Rating Agencies, and the Media. Genelex has been repeatedly recognized for our commitment to excellence. More than 99% of our customers respond positively to our regular follow-up surveys. An independent Dun & Bradstreet Past Performance Survey rated Genelex in the 90th percentile or above in cost, timeliness, customer support, overall reliability, and quality. Even Oprah Winfrey, CNN, and The New York Times choose Genelex when looking for experts to explain DNA testing and comment on cases in the news. Click here to view an independent external survey of our performance. Click here to see our management team.
Last Reviewed 8/20/10 |